1	Thrombospondin-2	Thrombospondin-2	B-NP	NN	B-protein	2	SUB	0
2	plays	play	B-VP	VBZ	O	0	ROOT	0
3	a	a	B-NP	DT	O	5	NMOD	0
4	protective	protective	I-NP	JJ	O	5	NMOD	0
5	role	role	I-NP	NN	O	2	OBJ	0
6	in	in	B-PP	IN	O	2	VMOD	0
7	multistep	multistep	B-NP	JJ	O	8	NMOD	0
8	carcinogenesis	carcinogenesis	I-NP	NN	O	6	PMOD	0
9	:	:	O	:	O	2	P	0
10	a	a	B-NP	DT	O	15	NMOD	0
11	novel	novel	I-NP	JJ	O	15	NMOD	0
12	host	host	I-NP	NN	O	15	NMOD	0
13	anti-tumor	anti-tumor	I-NP	JJ	O	15	NMOD	0
14	defense	defense	I-NP	NN	O	15	NMOD	18	defense
15	mechanism	mechanism	I-NP	NN	O	2	OBJ	0
16	.	.	O	.	O	2	P	0

1	The	The	B-NP	DT	O	3	NMOD	0
2	angiogenic	angiogenic	I-NP	JJ	O	3	NMOD	3	angiogenic
3	switch	switch	I-NP	NN	O	6	SUB	0
4	during	during	B-PP	IN	O	3	NMOD	0
5	tumorigenesis	tumorigenesis	B-NP	NN	O	4	PMOD	0
6	is	be	B-VP	VBZ	O	0	ROOT	0
7	thought	think	I-VP	VBN	O	6	VC	0
8	to	to	I-VP	TO	O	9	VMOD	0
9	be	be	I-VP	VB	O	7	VMOD	0
10	induced	induce	I-VP	VBN	O	9	VC	17	induced
11	by	by	B-PP	IN	O	10	VMOD	0
12	a	a	B-NP	DT	O	13	NMOD	0
13	change	change	I-NP	NN	O	11	PMOD	0
14	in	in	B-PP	IN	O	13	NMOD	0
15	the	the	B-NP	DT	O	16	NMOD	0
16	balance	balance	I-NP	NN	O	14	PMOD	0
17	of	of	B-PP	IN	O	16	NMOD	0
18	pro-	pro-	B-NP	JJ	O	22	NMOD	0
19	angiogenic	angiogenic	I-NP	JJ	O	22	NMOD	3	angiogenic
20	and	and	I-NP	CC	O	22	NMOD	0
21	anti-angiogenic	anti-angiogenic	I-NP	JJ	B-protein	22	NMOD	3	angiogenic
22	factors	factor	I-NP	NNS	I-protein	17	PMOD	0
23	.	.	O	.	O	6	P	0

1	To	To	B-VP	TO	O	2	VMOD	0
2	elucidate	elucidate	I-VP	VB	O	20	VMOD	0
3	the	the	B-NP	DT	O	5	NMOD	0
4	biological	biological	I-NP	JJ	O	5	NMOD	0
5	role	role	I-NP	NN	O	2	OBJ	0
6	of	of	B-PP	IN	O	5	NMOD	0
7	the	the	B-NP	DT	O	11	NMOD	0
8	endogenous	endogenous	I-NP	JJ	O	11	NMOD	0
9	angiogenesis	angiogenesis	I-NP	NN	O	11	NMOD	3	angiogenesis
10	inhibitor	inhibitor	I-NP	NN	O	11	NMOD	18	inhibitor
11	thrombospondin-2	thrombospondin-2	I-NP	NN	B-protein	6	PMOD	0
12	(	(	O	(	O	14	DEP	0
13	TSP-2	TSP-2	B-NP	NN	B-protein	14	DEP	0
14	)	)	O	)	O	11	NMOD	0
15	during	during	B-PP	IN	O	5	NMOD	0
16	multistep	multistep	B-NP	JJ	O	17	NMOD	0
17	carcinogenesis	carcinogenesis	I-NP	NN	O	15	PMOD	0
18	,	,	O	,	O	20	P	0
19	we	we	B-NP	PRP	O	20	SUB	0
20	subjected	subject	B-VP	VBD	O	0	ROOT	19	subjected
21	TSP-2-deficient	TSP-2-deficient	B-NP	JJ	O	24	NMOD	9	deficient
22	and	and	I-NP	CC	O	24	NMOD	0
23	wild-type	wild-type	I-NP	JJ	O	24	NMOD	0
24	mice	mouse	I-NP	NNS	O	20	OBJ	0
25	to	to	B-PP	TO	O	20	VMOD	0
26	a	a	B-NP	DT	O	30	NMOD	0
27	chemical	chemical	I-NP	JJ	O	30	NMOD	0
28	skin	skin	I-NP	NN	O	30	NMOD	0
29	carcinogenesis	carcinogenesis	I-NP	NN	O	30	NMOD	0
30	regimen	regimen	I-NP	NN	O	25	PMOD	0
31	.	.	O	.	O	20	P	0

1	Surprisingly	Surprisingly	B-ADVP	RB	O	5	VMOD	0
2	,	,	O	,	O	5	P	0
3	TSP-2	TSP-2	B-NP	NN	B-protein	4	NMOD	0
4	expression	expression	I-NP	NN	O	5	SUB	9	expression
5	was	be	B-VP	VBD	O	0	ROOT	0
6	strongly	strongly	I-VP	RB	O	5	VMOD	0
7	upregulated	upregulate	I-VP	VBN	O	5	VC	17	upregulated
8	in	in	B-PP	IN	O	7	VMOD	0
9	the	the	B-NP	DT	O	11	NMOD	0
10	mesenchymal	mesenchymal	I-NP	JJ	O	11	NMOD	0
11	stroma	stroma	I-NP	NN	O	8	PMOD	0
12	of	of	B-PP	IN	O	11	NMOD	0
13	wild-type	wild-type	B-NP	JJ	O	14	NMOD	0
14	mice	mouse	I-NP	NNS	O	12	PMOD	0
15	throughout	throughout	B-PP	IN	O	7	VMOD	0
16	the	the	B-NP	DT	O	18	NMOD	0
17	consecutive	consecutive	I-NP	JJ	O	18	NMOD	0
18	stages	stage	I-NP	NNS	O	15	PMOD	0
19	of	of	B-PP	IN	O	18	NMOD	0
20	tumorigenesis	tumorigenesis	B-NP	NN	O	19	PMOD	0
21	whereas	whereas	B-PP	IN	O	5	VMOD	0
22	the	the	B-NP	DT	O	24	NMOD	0
23	angiogenesis	angiogenesis	I-NP	NN	B-protein	24	NMOD	3	angiogenesis
24	factor	factor	I-NP	NN	I-protein	29	NMOD	0
25	,	,	O	,	O	29	P	0
26	vascular	vascular	B-NP	JJ	B-protein	29	NMOD	0
27	endothelial	endothelial	I-NP	JJ	I-protein	29	NMOD	0
28	growth	growth	I-NP	NN	I-protein	29	NMOD	0
29	factor	factor	I-NP	NN	I-protein	31	SUB	0
30	,	,	O	,	O	29	P	0
31	was	be	B-VP	VBD	O	21	SBAR	0
32	induced	induce	I-VP	VBN	O	31	VC	17	induced
33	predominantly	predominantly	B-ADVP	RB	O	34	PMOD	0
34	in	in	B-PP	IN	O	32	VMOD	0
35	tumor	tumor	B-NP	NN	B-cell_type	36	NMOD	0
36	cells	cell	I-NP	NNS	I-cell_type	34	PMOD	0
37	.	.	O	.	O	5	P	0

1	TSP-2	TSP-2	B-NP	NN	B-protein	2	NMOD	0
2	deficiency	deficiency	I-NP	NN	O	4	SUB	9	deficiency
3	dramatically	dramatically	B-ADVP	RB	O	4	VMOD	0
4	enhanced	enhance	B-VP	VBD	O	0	ROOT	0
5	susceptibility	susceptibility	B-NP	NN	O	4	OBJ	0
6	to	to	B-PP	TO	O	5	NMOD	0
7	skin	skin	B-NP	NN	O	8	NMOD	0
8	carcinogenesis	carcinogenesis	I-NP	NN	O	6	PMOD	0
9	and	and	O	CC	O	4	VMOD	0
10	resulted	result	B-VP	VBD	O	4	VMOD	0
11	in	in	B-PP	IN	O	10	VMOD	0
12	accelerated	accelerate	B-NP	VBN	O	14	AMOD	0
13	and	and	I-NP	CC	O	14	AMOD	0
14	increased	increase	I-NP	VBN	O	16	NMOD	17	increased
15	tumor	tumor	I-NP	NN	O	16	NMOD	0
16	formation	formation	I-NP	NN	O	11	PMOD	2	formation
17	.	.	O	.	O	4	P	0

1	The	The	B-NP	DT	O	3	NMOD	0
2	angiogenic	angiogenic	I-NP	JJ	O	3	NMOD	3	angiogenic
3	switch	switch	I-NP	NN	O	4	SUB	0
4	occurred	occur	B-VP	VBD	O	16	VMOD	0
5	in	in	B-PP	IN	O	4	VMOD	0
6	early	early	B-NP	JJ	O	7	NMOD	0
7	stages	stage	I-NP	NNS	O	5	PMOD	0
8	of	of	B-PP	IN	O	7	NMOD	0
9	pre-malignant	pre-malignant	B-NP	JJ	O	11	NMOD	0
10	tumor	tumor	I-NP	NN	O	11	NMOD	0
11	formation	formation	I-NP	NN	O	8	PMOD	2	formation
12	,	,	O	,	O	16	P	0
13	and	and	O	CC	O	16	VMOD	0
14	tumor	tumor	B-NP	NN	O	15	NMOD	0
15	angiogenesis	angiogenesis	I-NP	NN	O	16	SUB	3	angiogenesis
16	was	be	B-VP	VBD	O	0	ROOT	0
17	significantly	significantly	I-VP	RB	O	16	VMOD	0
18	enhanced	enhance	I-VP	VBN	O	16	VC	17	enhanced
19	in	in	B-PP	IN	O	18	VMOD	0
20	TSP-2-deficient	TSP-2-deficient	B-NP	JJ	O	21	NMOD	9	deficient
21	mice	mouse	I-NP	NNS	O	19	PMOD	0
22	.	.	O	.	O	16	P	0

1	While	While	B-SBAR	IN	O	0	ROOT	0
2	TSP-2	TSP-2	B-NP	NN	B-protein	3	NMOD	0
3	deficiency	deficiency	I-NP	NN	O	4	SUB	9	deficiency
4	did	do	B-VP	VBD	O	1	SBAR	0
5	not	not	I-VP	RB	O	4	VMOD	0
6	affect	affect	I-VP	VB	O	4	VC	16	affect
7	tumor	tumor	B-NP	NN	O	14	NMOD	0
8	differentiation	differentiation	I-NP	NN	O	7	NMOD	2	differentiation
9	or	or	I-NP	CC	O	7	NMOD	0
10	proliferation	proliferation	I-NP	NN	O	7	NMOD	4	proliferation
11	,	,	O	,	O	14	P	0
12	tumor	tumor	B-NP	NN	O	14	NMOD	0
13	cell	cell	I-NP	NN	O	14	NMOD	0
14	apoptosis	apoptosis	I-NP	NN	O	15	SUB	5	apoptosis
15	was	be	B-VP	VBD	O	6	VMOD	0
16	significantly	significantly	I-VP	RB	O	15	VMOD	0
17	reduced	reduce	I-VP	VBN	O	15	VC	18	reduced
18	.	.	O	.	O	1	P	0

1	These	These	B-NP	DT	O	2	NMOD	0
2	results	result	I-NP	NNS	O	3	SUB	0
3	reveal	reveal	B-VP	VBP	O	0	ROOT	0
4	upregulation	upregulation	B-NP	NN	O	16	SUB	0
5	of	of	B-PP	IN	O	4	NMOD	0
6	an	an	B-NP	DT	O	9	NMOD	0
7	endogenous	endogenous	I-NP	JJ	O	9	NMOD	0
8	angiogenesis	angiogenesis	I-NP	NN	O	9	NMOD	3	angiogenesis
9	inhibitor	inhibitor	I-NP	NN	O	5	PMOD	0
10	during	during	B-PP	IN	O	4	NMOD	0
11	multi	multi	B-NP	JJ	O	13	NMOD	0
12	step	step	I-NP	NN	O	13	NMOD	0
13	tumorigenesis	tumorigenesis	I-NP	NN	O	15	NMOD	0
14	and	and	I-NP	CC	O	15	NMOD	0
15	identify	identify	I-NP	NN	O	10	PMOD	0
16	enhanced	enhance	B-VP	VBD	O	3	VMOD	17	enhanced
17	stromal	stromal	B-NP	JJ	O	19	NMOD	0
18	TSP-2	TSP-2	I-NP	NN	B-protein	19	NMOD	0
19	expression	expression	I-NP	NN	O	16	OBJ	9	expression
20	as	as	B-PP	IN	O	16	VMOD	0
21	a	a	B-NP	DT	O	26	NMOD	0
22	novel	novel	I-NP	JJ	O	26	NMOD	0
23	host	host	I-NP	NN	O	26	NMOD	0
24	anti-tumor	anti-tumor	I-NP	JJ	O	26	NMOD	0
25	defense	defense	I-NP	NN	O	26	NMOD	18	defense
26	mechanism	mechanism	I-NP	NN	O	20	PMOD	0
27	.	.	O	.	O	3	P	0

